Skip to main content
ADXN
NASDAQ Life Sciences

Neurosterix Closes $105M Series B; Addex Stake Diluted to 8.5%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.89
Mkt Cap
$3.334M
52W Low
$2.56
52W High
$11.97
52W Position info
13% above low
Off High info
76% below high
Rel. Volume
Market data snapshot near publication time

ADXN is trading near its 52-week low of $2.56 (13% above the low).

Summary

Addex's spin-out Neurosterix closed a $105 million Series B from a syndicate of life science investors. Addex did not put money in, so its stake fell from 20% to 8.5% of Neurosterix, now carried at an $18.6 million valuation. The cash is earmarked mainly for Phase 2 development of NTX-253, the M4 PAM for schizophrenia that cleared Phase 1, plus the broader neuropsychiatric pipeline. For a company with a roughly $3.3 million market cap that flagged going-concern doubt in its H1 report, an $18.6 million stake in a well-funded private asset is the bulk of the story — it is a mark-to-market gain on the balance sheet, not cash in Addex's hands. The dilution of the ownership percentage is the trade-off; Addex keeps upside through the smaller stake but no longer controls the program's financing.

At the time of this announcement, ADXN was trading at $2.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $2.56 to $11.97. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADXN - Latest Insights

ADXN
Sep 28, 2026, 7:06 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.73
Real-time Price: $5.65 info
Change: Low Volume info
Market Cap: $3.334M info
ADXN
Sep 25, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.70
Real-time Price: $5.65 info
Change: Low Volume info
Market Cap: $3.334M info
ADXN
Aug 26, 2026, 1:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.74
Real-time Price: $5.65 info
Change: Low Volume info
Market Cap: $3.334M info
ADXN
Jun 30, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $5.65 info
Change: Low Volume info
Market Cap: $3.334M info
ADXN
Jun 25, 2026, 6:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $6.00
Real-time Price: $5.65 info
Change: Low Volume info
Market Cap: $3.334M info